Integrated Advisors Network’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Sell
1,279
-186
-13% -$36.1K 0.01% 601
2025
Q4
$254K Sell
1,465
-99
-6% -$18K 0.01% 636
2025
Q3
$298K Sell
1,564
-19
-1% -$3.37K 0.01% 631
2025
Q2
$284K Sell
1,583
-1,702
-52% -$296K 0.01% 632
2025
Q1
$556K Buy
3,285
+1,281
+64% +$210K 0.03% 442
2024
Q4
$302K Sell
2,004
-100
-5% -$15.6K 0.01% 566
2024
Q3
$327K Sell
2,104
-23
-1% -$3.44K 0.02% 571
2024
Q2
$291K Sell
2,127
-30
-1% -$4.11K 0.01% 575
2024
Q1
$287K Hold
2,157
0.01% 607
2023
Q4
$297K Buy
2,157
+259
+14% +$34K 0.02% 556
2023
Q3
$231K Sell
1,898
-96
-5% -$12.8K 0.01% 600
2023
Q2
$280K Sell
1,994
-2,799
-58% -$386K 0.02% 561
2023
Q1
$678K Buy
4,793
+2,602
+119% +$372K 0.04% 356
2022
Q4
$343K Buy
+2,191
New +$315K 0.02% 488
2021
Q1
Sell
-17,857
Closed -$2.13M 550
2020
Q4
$2.13M Sell
17,857
-11
-0.1% -$1.34K 0.23% 123
2020
Q3
$2.05M Buy
+17,868
New +$2.11M 0.26% 107

Other funds holding DGX

Integrated Advisors Network's DGX Position: Q1 2026 in Review

Integrated Advisors Network reduced its Quest Diagnostics (DGX) stake by 13% in Q1 2026, selling an estimated $36.1K and leaving 1,279 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #601.

Integrated Advisors Network first reported a position in DGX in Q3 2020 and has held it in 16 quarters since. The position peaked at $2.13M in Q4 2020. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Integrated Advisors Network held 1,279 shares of Quest Diagnostics worth $251K as of Q1 2026.
  • Integrated Advisors Network sold 186 Quest Diagnostics shares in Q1 2026, an estimated $36.1K.
  • Quest Diagnostics made up 0.01% of Integrated Advisors Network's portfolio in Q1 2026, its #601 holding.
  • Integrated Advisors Network first reported a position in Quest Diagnostics in Q3 2020 and has held it in 16 quarters since.
  • Integrated Advisors Network's Quest Diagnostics position peaked at $2.13M in Q4 2020.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.